{
    "Trade/Device Name(s)": [
        "Cepheid Xpert SA Nasal Complete Control Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K191168",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182472"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "April 30, 2019",
    "Summary Letter Received Date": "May 1, 2019",
    "Submission Date": "June 10, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed Quality Control Material For Clinical Microbiology Assays"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-Resistant Staphylococcus aureus",
        "Staphylococcus aureus",
        "Staphylococcus epidermidis"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing",
        "Extraction",
        "Amplification",
        "Detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control Panel",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert SA Nasal Complete Control Panel used as quality control in nucleic acid testing for MRSA and SA detection on the GeneXpert Dx System",
    "Indications for Use Summary": "Intended for use as external assayed positive and negative quality control to monitor in vitro laboratory nucleic acid testing procedures for qualitative detection of Methicillin-Resistant Staphylococcus aureus and Staphylococcus aureus on the Cepheid Xpert SA Nasal Complete Assay with the GeneXpert Dx System",
    "fda_folder": "Microbiology"
}